expressed in the sinusoidal endothelial cells of liver, spleen, and lymph nodes and acts as a scavenging receptor that clears hyaluronan and other glycosaminoglycans from the blood. 14 Tolllike receptors-2 and -4 mainly recognize hyaluronan oligomers in dendritic cells during inflammatory events. 15 Natural high molecular weight HA (HMWHA) under certain pathological inflammatory conditions can be degraded by hyaluronidases to produce lower molecular weight HA fragments (LMWHA) and oligosaccharide HA (oligo HA, ∼10À20 sugars in length) which are found in tissue injury and certain tumors. 16, 17 HA of different MW forms bind to CD44 receptor but elicit different effects on cellular functions. For example, HMWHA is antiangiogenic, whereas LMWHA and oligo HA can induce angiogenic responses. 18, 19 Similarly, high and low MW forms of HA provoke distinct anti-inflammatory and proinflammatory effects, respectively, upon binding to CD44. 20 Different molecular sizes of HA have differential effects on the rate of early wound contraction. 21 The MW of HA also significantly impacts its biodistribution, 22 cellular permeability, 23 and ligandÀreceptor interaction. 24 Consequently, the effect of HA MW should be investigated for any ligand-targeted DDS that uses HA as the targeting moiety.
HA has been coated on the liposome surface as a bioadhesive NP 25 or targeted NPs to deliver mitomycin C or doxorubicin to melanoma cells. 26, 27 The HA coating provides a hydrophilic shield, similar to polyethylene glycol (PEG), for promotion of long blood circulation. Further, the addition of HA also provides targeting for CD44 positive cells. However, it remains unclear how HA size influences its targeting properties and how the surface HA ligand density affects the cellular internalization and intracellular trafficking of HA-grafted liposomes. Therefore, the aims of the current study were to delineate the influences of HA molecular weight and grafting density, as well as cellular CD44 receptor expression level, on the cellular uptake of HAÀliposomes and to determine the intracellular localization of HAÀliposomes.
' EXPERIMENTAL SECTION Chemicals. L-R-Phosphatidylcholine, egg, chicken (Egg PC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), lissamine rhodamine PE (Rh-PE), and cholesterol were purchased from Avanti Polar Lipids (Alabaster, AL). Hyaluronan of various MWs (5À8, 10À12, and 175À350 kDa) was purchased from Lifecore Biomedical (Chaska, MN). High MW hyaluronan (HMWHA, 1600 kDa, sodium salt from Streptococcus equi), hexadecyltrimethylammonium bromide (CTAB), 1-ethyl-3-(3dimethylaminopropyl)carbodiimide (EDC), N-hydroxysulfosuccinamide (NHSS), chlorpromazine, amiloride, methyl-β-cyclodextrin, filipin III, nystatin, and Nile Red were purchased from Sigma-Aldrich (St. Louis, MO). Sodium acetate and phosphatebuffered saline (PBS) were purchased from Fisher Scientific (Pittsburgh, PA). DAPI (4,6-diamidino-2-phenylindole), Lyso-Tracker Green (DND-26), and Texas Red dextran (MW 3 kDa) were purchased from Invitrogen (Carlsbad, CA). Fluoresceinlabeled hyaluronans of various MWs (FL-HA) were synthesized based on a published method, 28 and the degree of substitution of fluorescein was determined by fluorescence intensity analysis using fluorescein sodium as standard (Supporting Information). Texas Red labeled 5À8 kDa hyaluronan (TR-HA) was made according to a published method. 29 All other chemicals were purchased from Sigma-Aldrich and were of standard analytic grade or higher.
Cell Culture. Human lung carcinoma epithelial cell line A549 and human breast cancer cell lines MDA-MB-231 and MCF7 were obtained from ATCC (Manassas, VA). A549 cells were maintained in RPMI-1640 medium (Mediatech, Inc.; Manassas, VA) supplemented with 10% fetal bovine serum (FBS) (Gibco, Invitrogen). MDA-MB-231 and MCF7 cells were cultured in RPMI-1640 medium with 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin and incubated at 37°C in a humidified atmosphere with 5% CO 2 .
Hyaluronan-Conjugated Liposome Preparation and Characterization. Plain (unsubstituted) liposomes were prepared by thin lipid film hydration and extrusion method. Briefly, a homogeneous chloroform solution of the lipid components (PC:PE: Chol in 65:5:30 molar ratios) was evaporated and the resulting lipid film was dried under vacuum overnight. Films were hydrated in phosphate buffered saline (PBS) with an initial total lipid concentration of 5À10 mM. The suspension was bath-sonicated for 30 min, followed by extrusion through stacked 100 nm pore size polycarbonate membranes (Nucleopore, Whatman Inc., Piscataway, NJ) using a hand-held extruder (Avestin Inc., Ottawa, ON, Canada).
To prepare HA-conjugated liposomes (HAÀliposome), we used a method similar to that reported by Yerushalmi et al., 25 where different MWs of HA were hydrated in water (pH 4.0) overnight to allow swelling and complete solubilization. After the addition of the coupling agents EDC and NHSS to activate HA, the pH of the solution was back-titrated to 4.0 using 1 M HCl. The solution was then incubated for an additional 2 h at 37°C before being transferred to 1 mL of PE-containing plain liposome suspension (pH 8.6) for overnight stirring at 37°C. The excess reagents and free HA were removed as the supernatant after three cycles of ultracentrifugation at 150000g. Rhodamine labeled PE (Rh-PE) at 0.5 mol % was used as the fluorescent lipid in formulations prepared for the fluorescence microscopy studies. Fluorescent dye Nile Red at 1 mol % served as a fluorescence probe in liposome formulations used in flow cytometry studies. Nile Red loaded liposomes were subjected to low velocity centrifugation and gel filtration on a Sephadex G-25 column to separate unentrapped Nile Red. After separation, all Nile Red liposomes were used immediately for cellular uptake assays. Less than 5% free dye released from formulations after 2 h incubation in medium determined by equilibrium dialysis. The liposome particle size, zeta potential, and polydispersity were measured by dynamic light scattering analysis of dilute samples using a Nicomp 380/ZLS particle sizing analyzer (Santa Barbara, CA).
Determination of the Concentration of Hyaluronan. The amount of unconjugated (free) HA in the supernatants after ultracentrifugation was quantified using the published hexadecyltrimethylammonium bromide (CTAB) turbidimetric method with modification. 30 Briefly, 50 μL of HA standard solutions (0.1À2 mg/mL) or diluted supernatants were added to a 96-well plate. The samples were incubated with 50 μL of 0.2 M sodium acetate buffer for 10 min at 37°C. Then, 100 μL of 10 mM CTAB solution was added to the mixture, and the absorbance of the precipitated complex was read within 10 min against the blank at 570 nm using a microplate reader (BioTek Instruments, Inc., Winooski, VT). The amount of conjugated HA was calculated by subtracting the amount in the supernatant fraction from the initial amount added to the reaction mixture.
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Receptor Expression Analysis. CD44 expression levels were determined by combined flow cytometry, immunocytostaining, and Western blot analysis. For flow cytometry analysis, 0.5 Â 10 6 cells were incubated with the fluorescein isothiocyanate (FITC)conjugated mouse anti-human CD44 monoclonal antibody (BD Pharmingen, San Diego, CA) for 30 min at 4°C. FITC mouse IgG 2b k antibody was used as isotype control. Cells also were incubated with 50 μg/mL of FL-HMWHA in PBS at 4°C for 30 min, washed three times with ice cold PBS, and resuspended in 0.4 mL PBS. The fluorescence intensity was analyzed using flow cytometry as described below. For immunocytostaining, exponentially growing cells were plated on sterile coverslips (12 mm) placed in a 12-well plate at a density of 50,000 cells per well, and cells were allowed to attach overnight. The cells were then washed three times with PBS, followed by fixation with an ice cold acetone:methanol mixture (50:50 v/v) for 5 min. Fixed cells were stained using anti-human CD44H (clone 2C5, R&D Systems) as primary antibody and Alexa Fluor 546 labeled goat anti-human antibody (Invitrogen) as secondary antibody. Cells were counterstained with 2 μg/mL DAPI for nuclear recognition prior to imaging on the fluorescent microscope. For Western blot analysis, cells were lysed at 4°C in RIPA buffer. Proteins extracted from cells were resolved by SDSÀPAGE, electrophoretically transferred onto polyvinylidene membrane, and probed with CD44H antibody (R&D Systems). β-Actin antibody was used for equal loading control. Specific proteins were visualized with enhanced chemiluminescence detection reagent (Amersham Pharmacia). For cell surface RHAMM (CD168) receptor staining, cells were incubated with mouse anti-human monoclonal CD168 antibody (Abcam) or isotype control (IgG1) for 30 min at 4°C. Cells were washed and incubated with a goat anti-mouse IgG Alexa Fluor 488-conjugated antibody for 45 min at 4°C. Cells were then washed and resuspended in the FACS buffer and analyzed by flow cytometer.
Cellular Uptake Studies. Various HAÀliposomes carrying different amounts of low (5À8 and 10À12 kDa) and high (175À350 and 1600 kDa) molecular weight HA were prepared as described above. The cellular uptake of the formulations was then studied using tumor cell lines with different levels of CD44 receptor density with the aid of fluorescence microscopy (Rh-PE liposomes) and flow cytometry (Nile Red loaded liposomes). Briefly, 0.2À0.3 Â 10 6 cells per well were plated in a 12-well plate and allowed to attach overnight. The complete growth medium was replaced with the serum-and antibiotic-free medium containing Rh-PE labeled plain liposomes or various HAÀliposomes at a final total lipid concentration of 100 μM. Lipid concentration was determined spectrophotometrically at 560 nm based on Rh-PE lipid standards. The cells were incubated for 2 h at 37°C, and nucleus dye DAPI (2 μg/mL) was added 20 min before cells were visualized using fluorescence microscopy. For quantitative analysis, cells were incubated with Nile Red loaded plain liposomes or various HAÀliposomes in serum-and antibioticfree medium with a final Nile Red concentration of 0.5 μM. After 2 h of incubation, the cells were washed three times with ice cold PBS, then harvested and analyzed by flow cytometer. Cells incubated in media alone without any formulations served as the negative control for autofluorescence. To test whether the HAÀliposome uptake was mediated by CD44 receptor, the cells were pretreated with 10 mg/mL free HA polymer (175À350 kDa, hydrated overnight in serum-and antibiotic-free medium) for 1 h before addition of Rh-PE labeled or Nile Red labeled plain liposomes or various HAÀliposomes for an additional 2 h.
Fluorescence Microscopy. The localization of various fluorophores in cells was investigated with an Olympus IX81 inverted fluorescence microscope. Excitation and emission filters were, respectively, 360 ( 20 nm and 460 ( 25 nm for blue channel (DAPI), 470 ( 40 nm and 525 ( 50 nm for green channel (LysoTracker), and 560 ( 55 nm and 645 ( 75 nm for red channel (Rh-PE). Images were captured with a Hamamatsu CCD camera using a constant exposure time (25 ms for blue channel, and 100 ms for red channel). Fluorescence images were viewed using Slidebook 5.0 software (Olympus Inc., Center Valley, PA) in blue and red channels to visualize the presence of cells (DAPI, blue) and liposomes (Rh-PE, red) and in green channel to visualize the LysoTracker probe, and the overlay was used to show the cellular association of liposomes.
Flow Cytometry. A FACScan flow cytometer (BD Biosciences, San Jose, CA) equipped with a 488 nm laser was used to analyze Nile Red labeled liposomes (lipid-bound dye λ ex-max = 550 nm, λ em-max = 636 nm). At least 10,000 cells were analyzed for each experiment. The flow cytometric data were presented as frequency distribution histograms. The uptake of control liposomes was set as 100%, and the relative uptake of different treatments was presented as percentage of control. For the cells pretreated with different endocytic inhibitors, the mean cell fluorescence was normalized to that of the untreated cells. All experiments were repeated at least three times.
Endocytosis Inhibition. The effect of temperature on HAÀ liposome uptake was studied by incubating the A549 cells with the Nile Red containing HAÀliposomes for 2 h at 4°C. The effects of several membrane entry inhibitors on the uptake of HAÀliposomes were examined by preincubating the A549 cells with serum-free medium containing chlorpromazine (10 μg/mL), amiloride (25 μg/mL), methyl-β-cyclodextrin (5 mM), filipin III (5 μg/mL), or nystatin (25 μg/mL) for 1 h at 37°C, and then treating the cells with various Nile Red loaded HAÀliposomes or FL-HMWHA for an additional two hours. 31 The concentrations of inhibitors were based on the literature 32, 33 and were not cytotoxic. At the end of incubation, the adherent cells were washed twice with ice cold PBS and then trypsinized for a prolonged period of time (6 min) to dissociate the surface bound formulation. 34 Internalized HAÀliposomes were quantified by flow cytometry.
Intracellular Localization. A549 cells were treated with Rh-PE labeled liposomes for 2 h. The cells were then washed three times with PBS, followed by incubation with LysoTracker Green (150 nM for 5 min) and DAPI (2 μg/mL). The cells treated with Texas Red conjugated 5À8 kDa HA (600 μg/mL for 2 h) and Texas Red dextran (3 kDa, 500 μg/mL for 2 h) were used as controls. The stained cells were observed under the Olympus IX81 fluorescence microscope.
Statistical Analysis. Values are expressed as mean ( SEM unless stated otherwise. All statistical analysis was done using GraphPad Prism 5 software (San Diego, CA, USA). Differences between two means were tested using an unpaired, two-sided Student's t-test. Multiple group comparisons were performed by one-way ANOVA followed by Bonferroni's posttest analysis. Differences with p < 0.05 were considered significant.
' RESULTS CD44 Receptor Expression. We first used a combined method of flow cytometry, immunocytostaining, and Western blot analysis to quantitatively determine the relative surface expression levels of CD44 receptors in tumor cell lines. For flow Molecular Pharmaceutics ARTICLE cytometry, human breast cancer cell lines MCF7 and MDA-MB-231 and human lung cancer cell line A549 were directly stained with FITC-CD44 antibody (recognizes all CD44 isoforms). As shown in Figure 1A , all the tested cells showed higher binding to FITC-CD44 antibody than the isotype control, indicating the presence of CD44 receptors in these cells. However, the binding of FITC-CD44 antibody to the MCF7 cells was much lower than that of the MDA-MB-231 and A549 cells, suggesting relatively higher expressions of CD44 receptors in the MDA-MB-231 and A549 cells. The CD44 receptors are capable of binding to its endogenous ligand HMWHA, evidenced by the shift of the fluorescence peak to higher intensity upon staining the cells with fluorescein-labeled HA (FL-HMWHA, 1600 kDa). The CD44 receptor expressions also were visualized using immunocytostaining. Very little red fluorescence (representative of binding of anti-CD44 antibody) was associated with MCF7 cells compared to MDA-MB-231 and A549 cells, which displayed a strong staining for this adhesion molecule CD44 ( Figure 1B) . Western blot analysis of whole cell lysate further confirmed the relatively low expression of CD44 in MCF7 cells, and high expression in A549 and MDA-MB-231 cells ( Figure 1C ). Because RHAMM (CD168) receptor is also implicated in cancer, we studied the surface expression of CD168 in the same cells. Flow cytometry results showed weak expression of CD168 in MDA-MB-231 cells and almost no surface expression in MCF7 and A549 cells ( Figure 1A ). Therefore, we focused on CD44 as principal hyaluronan receptor in the following study.
HAÀLiposome Characterization. The reasons for making hydrophilic HA-functionalized liposomes are to improve the "stealth" properties of liposomes and to provide CD44 receptormediated active tumor targeting. Hyaluronan-conjugated liposomes (HAÀliposomes) were obtained by covalent linkage of the glucuronic acid moiety of the targeting ligand HA to the primary amine of DOPE of the preformed liposomes using EDC/NHSS coupling chemistry. As shown in Figure 2A , the HAÀliposomes displayed negative zeta potentials, indicating successful conjugation because HA is polyanionic at physiological pH. The particle sizes of the plain liposomes and HAÀliposomes ranged from 120 to 180 nm. There was a trend toward an increase in the particle size of HAÀliposomes as the MW of HA increased from 5À8 kDa to 1600 kDa. The polydispersity index of HAÀliposomes was below 0.3 for all the formulations, indicating limited variation in particle size. However, the 1600 kDa HAÀliposomes consistently showed higher polydispersity index from batch to batch, likely due to the highly polydisperse nature of HMWHA. 
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The HA ligand density on the surface of liposomes can potentially affect its cellular binding and molecular targeting. To precisely measure and control the ligand density, we analyzed the HA concentration using the CTAB turbidimetric method. CTAB is a cationic surfactant that readily precipitates the polyanionic HA to form a complex with strong light absorption at 570 nm. When the initial amount of HA (5À8 kDa) added to the liposome mixture increased from 1 to 5 mg, the amount of HA conjugated to the liposomes increased proportionally from 0.38 to 1.48 mg ( Figure 2B ). Further addition of HA did not dramatically improve the surface coverage of HA, but increased the viscosities of the particles, especially for the highly viscous and elastic HMWHA (1600 kDa) (data not shown). Thus, we used 5 mg of various sizes of HA as the starting material to make all the HAÀliposomes with the HA to lipids ratio (μg HA/μmol lipids) ranging from 267 to 613 μg/μmol (Figure 2A ).
Effect of HA Grafting Density on Cellular Uptake of HAÀLiposomes. To determine whether an optimal HA ligand density for maximal tumor cell targeting exists, the cellular uptakes of HAÀliposomes with different HA ligand densities were visualized and quantified using fluorescence microscopy (Rh-PE labeled HAÀliposomes) and flow cytometry (Nile Red loaded HAÀliposomes), respectively. Rh-PE is a fluorescent rhodamine labeled lipid that is part of liposome components and displays red fluorescence. Nile Red is a lipophilic fluorescent dye that mainly partitions into the liposome bilayers and can be excited with 488 nm laser. We controlled the density of HA ligand coated onto the liposome surface by the addition of 0.5 and 5 mg of 5À8 kDa HA for the coupling reaction, which resulted in the final HA conjugation of approximately 0.2 and 1.5 mg, respectively. We studied the cellular uptake of these 5À8 kDa HAÀliposomes with two HA grafting densities in comparison to plain liposomes. As shown in Figure 2C , cellular uptake of the Rh-PE labeled plain liposomes was similar to that of the 5À8 kDa HAÀliposome with the low grafting density, as demonstrated by similar red fluorescence in the cells exposed to these two formulations. In contrast, cells treated with the HAÀliposomes with the high grafting density (1.5 mg of surface anchored HA) showed significantly higher red fluorescence associated with cells. These qualitative results were confirmed by quantitative flow cytometric analysis using Nile Red loaded 5À8 kDa HAÀliposomes. The mean fluorescence uptake of HAÀliposomes with 1.5 mg of surface HA was significantly higher than that of the plain liposomes and HAÀliposomes with only 0.2 mg of surface HA (p < 0.05, one way ANOVA, Figures 2D, 2E ). This finding suggests that a critical density of the ligand is required on the surface of the liposomes to bind to CD44 receptor effectively.
Effect of HA Molecular Weight on the Cellular Uptake of HAÀLiposomes. To study the effect of size of HA ligand on the efficacy of targeted delivery, we first analyzed the binding affinity of fluorescein-labeled HA (FL-HA) of defined molecular sizes to cells of varying levels of CD44 receptor using flow cytometry. FL-HA has proven to be a sensitive and specific probe for testing HA binding function of CD44. 35, 36 Measurement of the fluorescence intensity of FL-HA indicated the HA disaccharide-to-fluorescein molar ratios were approximately 21, 23, 27, and 26, for 5À8 kDa, 10À12 kDa, 175À350 kDa, and 1600 kDa FL-HA, respectively. Figure 3A showed an increase in binding to A549 cells with increasing molecular size of FL-HA (5À8 ≈ 10À12 < 175À350 < 1600 kDa). We observed similar patterns in MCF7 and MDA-MB-231 cells ( Figure S1 in the Supporting Information). Next, we prepared a series of liposomes functionalized with different MWs of HA [5À8, 10À12, and 175À350 kDa, with high grafting density (∼ 1.5 mg HA)] and evaluated their cellular internalization. The 1600 kDa HA was not included due to its high polydispersity, high viscosity, and difficulty to remove unconjugated HMWHA. Fluorescence microscopy data showed that increasing the size of HA led to an increased A549 cellular uptake of Rh-PE labeled HAÀliposomes ( Figure 3B ). This trend was Figure S2 in the Supporting Information). The quantitative flow cytometric analysis of Nile Red loaded liposomes showed that the mean fluorescence intensity of the liposomes conjugated to 175À350 kDa-HA was 30À40% higher than that of liposomes conjugated to lower molecular weight HA (5À8 or 10À12 kDa, p < 0.0001, one way ANOVA, Figure 3C ) in A549 cells. We also determined concentration dependent binding and internalization of HAÀliposomes in A549 cells. A statistically significant increase in binding and internalization of liposomes (plain <5À8 kDa HAÀliposome <175À350 kDa HAÀliposome) was observed when cells were treated with increasing concentrations of Nile Red loaded HAÀliposomes (0.5À10 μM Nile Red, 0.1À2 mM total lipids, p < 0.001, two-way ANOVA, Figure 3D ). These data suggest that the size of HA ligand is an important determinant of its cellular uptake, with higher MWs of HA resulting in better cellular adhesion and internalization of HAÀliposomes.
Effect of HA Blocking on Cellular Uptake of HAÀLiposomes.
To further verify if the uptake of the HAÀliposomes is specific to CD44 receptor, competitive binding experiments were performed by pretreating the A549 cells with a saturable amount of free HA (175À350 kDa) before HAÀliposome incubation. Fluorescence microscopy studies revealed that the ligand pretreatment did not change the fluorescence intensities of Rh-PE labeled plain liposomes, but significantly diminished the red fluorescence of HAÀliposomes (5À8, 10À12, and 175À350 kDa, Figure 4A ), indicating that the free ligand competes with the HAÀliposomes for receptor binding sites. Similar results were Figure S3 in the Supporting Information). Quantitative results were obtained by flow cytometry analysis ( Figures 4B and 4C) where, compared to the uptake of control cells without HA pretreatment, the cells pretreated with excess ligand had nearly 50À70% reduction in mean fluorescence in all the Nile Red loaded HA (5À8, 10À12, and 175À350 kDa)-conjugated liposomes ( Figure 4C , p < 0.01, Student's t-test). The ligand HA pretreatment had no effect on the uptake of Nile Red loaded plain liposomes ( Figure 4C) . These results suggest that the binding and internalization of these HAÀliposomes to A549 cells could be competitively inhibited by excess free HA, demonstrating that the HA cell surface receptors, predominantly CD44 receptors, mediate the interaction.
Influence of CD44 Surface Density on Cellular Uptake of HAÀLiposomes. To investigate whether the HAÀliposome uptake was dependent on the cell surface expression level of CD44 receptor, we used MCF7 (CD44 low expression) and A549 (CD44 high expression) to determine if higher expression of CD44 receptor translates into higher uptake of HAÀliposomes. Figure 5A showed that Rh-PE red fluorescence associated with 5À8 kDa HAÀliposomes was lower in MCF7 cells in comparison to that of A549 cells. The quantitative flow cytometric analysis showed that the relative uptake of Nile Red loaded HAÀliposomes (5À8 and 175À350 kDa) was significantly higher in A549 cells compared to MCF7 cells (p < 0.001, Student's t-test). These studies are in agreement with the CD44 receptor-mediated uptake of HAÀliposomes because the targeting efficiency is dependent on the cell surface receptor density.
The Endocytic Pathway of HAÀLiposomes. To further probe the intracellular transporting mechanism of these HAÀ liposomes, we studied the effects of temperature and several membrane entry inhibitors on cellular internalization of HAÀ liposomes. Extracellular materials are usually translocated across the cell membrane by endocytosis. We found that the incubation of HAÀliposomes with cells at 4°C, which inhibits all the active energy-mediated processes, reduces uptake of 5À8 kDa and 175À350 kDa HAÀliposomes by 68% and 53%, respectively, compared to uptake at 37°C. This finding indicates that HAÀ liposomes are taken up inside the cells via an energy-dependent endocytosis pathway.
To further elucidate the endocytic pathway, we used flow cytometry to study the effects of several membrane entry inhibitors on the cellular internalization of HAÀliposomes ( Figure 6 ). A549 cells were pretreated with individual inhibitors, at concentrations that were not cytotoxic to the cells, before incubation with 5À8 kDa and 175À350 kDa HA-conjugated liposomes. Cells treated in the absence of inhibitors were used as Molecular Pharmaceutics ARTICLE controls. Inhibition of clathrin-mediated uptake was tested by using chlorpromazine, which inhibits assembly and disassembly of clathrin. 37 Caveolae-mediated uptake was tested by filipin III and nystatin, which partition into membranes and sequester sterols. 38 Macropinocytosis, a mechanism that mainly contributes to antigen uptake by professional antigen-presenting cells, was tested by amiloride, a specific inhibitor of the Na + /H + exchange required for macropinocytosis. None of these inhibitors showed any significant effects on the uptake of both HAÀliposomes ( Figure 6 ). These results suggest that the CD44-mediated internalization of HAÀliposomes is independent of clathrin-coated vesicles or the caveolae or macropinocytosis pathways.
It has been reported that cholesterol and lipid rafts are involved in membrane trafficking. 39 Lipid rafts are plasma membrane microdomains rich in cholesterol, sphingolipids, and cell surface receptors. To examine the role of lipid rafts in the uptake of HAÀliposomes, the A549 cells were treated with methyl-βcyclodextrin (MβCD), a water-soluble cyclic glucopyranoside oligomer and an inhibitor of lipid rafts. MβCD can selectively deplete cholesterol and disrupt lipid rafts without being incorporated into the plasma membrane. 38, 40 As compared to the controls, cells treated with MβCD showed significantly reduced uptake of both 5À8 kDa and 175À350 kDa HAÀliposomes (Figure 6 , p < 0.0001, one-way ANOVA). To confirm the role of lipid rafts, we further repeated the study with fluorescein-conjugated high molecular weight HA (∼1600 kDa). Similar to the above results, the uptake of the fluorescent polymer was reduced by nearly 45% with MβCD pretreatment, compared to untreated cells ( Figure 6C and 6F, p < 0.0001, one way ANOVA). These results suggest that HAÀliposomes are taken up into the cells via the lipid raft-mediated endocytosis which is cholesterol-dependent and is inhibited by methyl-β-cyclodextrin pretreatment.
Cellular Localization of HAÀLiposomes. To investigate the intracellular localization of HAÀliposomes, we incubated the Rh-PE labeled plain liposomes or HAÀliposomes with A549 cells for 2 h and monitored internalization using fluorescence microscopy. We used LysoTracker Green (a cell-permeable weakly basic amine) to stain for the acidic compartments (endosomal and lysosomal vesicles) and DAPI to label the nucleus ( Figure 7A ). The red fluorescence from liposomes ( Figure 7B ) and green fluorescence from LysoTracker ( Figure 7C) were then visualized. We observed that the 175À350 kDa HAÀliposomes mainly localized in acidic compartments such as endosomal and lysosomal vesicles, as evidenced by colocalization of green and red fluorescence ( Figure 7D, 7E) . The magnified image of colocalization showed that Rh-PE labeled HAÀliposomes produced a very bright, punctuated pattern (red dots, Figure S4 in the Supporting Information) and a fraction of HAÀliposomes colocalized with LysoTracker Green. A smaller fraction of Figure 6 . Effect of endocytosis inhibitors on cellular uptake of Nile Red labeled 5À8 kDa HAÀliposomes (A, D), 175À350 kDa HAÀliposomes (B, E), and fluorescein-labeled HMWHA (C, F). Flow cytometry histogram shows the fluorescence intensities of unstained A549 cells (filled curve) and cells treated with HAÀliposomes (5À8, 175À350 kDa) or fluorescein-HMWHA without inhibitor pretreatment (green curve) or with chlorpromazine (CPM, 10 μg/mL, red curve) to inhibit clathrin-mediated endocytosis, methyl-β-cyclodextrin (MβCD, 5 mM, blue curve) to inhibit lipid raft-mediated endocytosis, amiloride (AMIL, 10 μg/mL, brown curve) to inhibit macropinocytosis, or filipin III (5 μg/mL, red curve) or nystatin (NYS, 25 μg/mL, dark blue curve) to inhibit caveolae-specific endocytosis. All inhibitors were preincubated for 1 h. The percentage of uptake was calculated based on the fluorescence intensity of cellular uptake without any pretreatment (100%) and is presented as mean ( SEM, n = 3À6, *** represents p < 0.0001 after one way ANOVA.
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5À8 kDa HAÀliposomes ( Figure 7F ) and plain liposomes ( Figure 7G ) also displayed partial colocalization with the Lyso-Tracker Green after 2 h of incubation. To further confirm the results, Texas Red labeled 3 kDa dextran, a probe known for labeling the lysosomal compartment, 41 was used as a positive control for lysosomal localization. As expected, Texas Red 3 kDa dextran was completely colocalized with the LysoTracker Green staining ( Figure 7H) . Additionally, we observed the colocalization of Texas Red conjugated 5À8 kDa HA with the LysoTracker Green ( Figure 7I) , which is consistent with the literature data indicating that free HA mainly resides in prelysosomal endosomes. 34 Taken together, these experiments suggest that the HAÀliposomes are predominantly localized in acidic endosome and lysosome compartments.
' DISCUSSION
Hyaluronan has been used as a drug carrier and a ligand on liposomal NP to actively target tumor cells. 9 High molecular weight HA was attached to liposomes as a bioadhesive formulation to adhere to the extracellular matrix for topical delivery. 42 Further, Peer et al. encapsulated anticancer drugs mitomycin C or doxorubicin into the HAÀliposome (HMWHA, ∼10 6 Da), which had a half-life slightly less than that of PEGylated "stealth" liposome and improved survival time in multiple cancer models. 26, 43 In another work, Szoka et al. attached a mixture of oligosaccharide HA (tetramer/hexamer/octamer) to PE lipid directly before liposome preparation and encapsulated doxorubicin to the oligo HAÀliposomes (HAL-DOX). The HAL-DOX exhibited 8.2-or 4.4-fold increase in potency, compared with the free doxorubicin, against the B16F10 melanoma cells in a transient-exposure or continuousexposure condition, respectively. 27 Moreover, large molecular weight HA-coated liposomes have been used recently for delivery of RNAi payloads 44, 45 or MRI contrast agents. 46 These data suggest that HA conjugation of DDS could potentially improve the delivery and effectiveness of anticancer drugs.
The above reports established the advantages of HAÀliposomes over nontargeted delivery systems. However, the effects of HA size and density on the delivery systemÀCD44 interaction in target cells of varying CD44 expression levels and the mechanisms of the HAÀliposome intracellular trafficking are largely unknown. The HAÀCD44 interactions and intracellular trafficking of the DDS affect the specific delivery of the cargo and its downstream effects, such as toxicity and pharmacodynamics. In the current study we have addressed these important issues, which are crucial for the rational design and optimization of CD44-targeted, hyaluronan-based nanotherapeutics for improved intracellular delivery.
The large molecular weight HA-coated liposomes were shown to improve cell uptake in A549 47 and MDA-MB-231 cells but not in MCF7 cells, 48 Our results confirmed the high expression of CD44 receptors in A549 and MDA-MB-231 cells, and low expression of CD44 in MCF7 cells. Furthermore, our results showed strong expression of surface CD44 receptor as compared to surface CD168 receptor in all cells, indicating that CD44, not CD168, is the principal HA receptor for mediating cellular uptake of HA-coated liposomes ( Figure 1A) . For MDA-MB-231 cells, a low level of CD168 receptor was observed, suggesting CD168 may make a minor contribution to cellular uptake of HAÀliposome in MDA-MB-231 cells. We did not study other hyaluronan receptors, because HARE receptor is mainly expressed in sinusoidal endothelial cells, 14 and Toll-like receptors-2 and -4 are mainly expressed in immune cells. 15 For ligand-targeted nanoparticle DDS, tuning the surface ligand density (for enhanced ligand coverage) is a key requirement for efficient cellular targeting and preferential drug delivery to malignant sites. The quantity of the surface anchored HA was not measured in previous studies. In the current study, we characterized the amount of HA conjugated on the surface of liposomes using the CTAB turbidimetric method. We observed that there was a minimum threshold of HA ligand grafting density that is required, above which efficient uptake of HAÀliposomes via the CD44 receptor occurs ( Figure 2E ). In addition to HA density, our results ( Figure 5 ) demonstrate that the degree of intracellular uptake of HAÀliposomes also depends on the receptor density of the cells; higher CD44 receptor density correlates with higher HAÀliposome uptakes. This property makes the HAÀliposome DDS system tumor-selective because many tumor cells overexpress CD44 receptor, which advantageously leads to improved HAÀliposome uptake. On the other hand, the normal cells with no or relatively low CD44 receptors will be minimally affected by the HA-targeted nanocarrier systems.
Our results (Figure 2A ) suggest that the physicochemical properties of the HAÀliposomes are affected by the MW of the HA. We observed a trend that mean particle sizes of the negatively charged HAÀliposomes progressively increased with an increase in the MW of HA (Figure 2A ). This is in agreement with the reported change in hydrodynamic radius of HA as a result of chain length; the hydrodynamic radius of HA polymer increases from 22 nm at 160 kDa to 36 nm at 350 kDa, to 56 nm at 800 kDa, to 81 nm at 1430 kDa. 49 Additionally, the MW of HA affected the charge of the HAÀliposome. Generally, as the MW of HA increased from 5À8 kDa to 1600 kDa, there was a substantial increase in the zeta potential of the nanoparticle (Figure 2A ). However, this relationship is not very clear if only the 5À8 kDa and 10À12 kDa HAÀliposomes are considered (Figure 2A) , perhaps because of the low and variable charge at this MW range (Figure 2A) . Nevertheless, the relationship between the polymer MW and charge may be complicated by other factors affecting the measurement of surface charge. For example, the surface charge can be influenced by the HA conformation adopted (e.g., fully relaxed chain, densely packed coils, or short thick rod), intermolecular hydrogen bonding between the carboxyl group and acetamido group, or surface interaction with lipids. Overall, these data suggest that the MW of HA contributes to both the size and charge of the HAÀliposomes.
In previous studies of HAÀliposomes, the HAs used were highly heterogeneous with respect to size. Because of different binding affinity and opposing biological effects with HMWHA and LMWHA, HA of defined molecular weight was used in the current study. The binding affinity of fluorescein-labeled HA to CD44 receptor increased with increasing size of HA (5À8 ≈ 10À12 < 175À350 < 1600 kDa) in all cell lines ( Figure 3A , Figure S1 in the Supporting Information). However, similar to previous observations, 35 the difference of binding affinity of LMWHA 5À8 and 10À12 kDa to CD44 receptor was not clearly detected by flow cytometry. Our results are consistent with earlier studies using 3 H-HA radioligand binding assay that showed high MW of HA had a higher binding affinity to SV-3T3 (simian virus 40-transformed Swiss mouse 3T3) cells than did smaller MW of HA, with dissociation constant (K d ) values of 3.4 Â 10 À9 M for the 4.5 Â 10 5 Da HA, 2.01 Â 10 À9 M for the 9.2 Â 10 5 Da HA, and 1.47 Â 10 À9 M for the 1.3 Â 10 6 Da HA. 50 The hyaluronan receptor in SV-3T3 cell was later proved to be CD44. 51 Similarly, the binding of 125 I-Tyr labeled HA (4.5 Â 10 5 Da) on a rat colon cancer cell line was competitively inhibited more effectively by HMWHA than LMWHA, with a K d value of 1.4 Â 10 À9 M. 52 Additionally, the size-dependence of 3 H-HA binding to liver endothelial cells was also demonstrated by a preference of cell surface binding for HMWHA; the dissociation constant decreased dramatically with an increasing size of HA, with K d values of 4.6 Â 10 À6 M for an octasaccharide HA, 0.2 Â 10 À6 M for HA of 35 sugar residues, 6 Â 10 À11 M for the 4 Â 10 5 Da HA, and 9 Â 10 À12 M for the 6.4 Â 10 6 Da HA. 53 A minimal binding site size of six sugar residues is required for HA binding to cell surface CD44. 35 This information indicates that the importance of molecular weight of HA in determining the its cellular binding efficiency. This molecular weight dependency was also observed in HAcoated liposomes. Increasing the MW of HA from 5À8 kDa to 175À350 kDa enhances the uptake of HAÀliposomes (Figures 3  and 5 ). This could be attributed to a higher binding affinity of high molecular weight HA to CD44 receptor, compared to low molecular weight HA ( Figure 3A) . 35 In addition, the longer polymeric chains of HA extending from the liposome surface improve ligand accessibility to the CD44 receptor and promote the multivalent binding to receptor. Our results are consistent with a recent study 24 on the free flexible HA polymer binding and adsorption on an adhesive surface coated with CD44, which showed that the binding of high molecular weight HA (>262 kDa) was irreversible. However, the binding became weaker and reversible with decreased HA molecular weight. 24 We demonstrated that the maximum HAÀliposomeÀCD44 receptor binding effect can be achieved by increasing either HA chain length (Figure 3 ) or grafting density (Figure 2E ). However, an inherent disadvantage of HMWHA as a polymer excipient is that it is quickly cleared from circulation by the liver and spleen. 54À56 Additionally, increasing the size of HA also increases the inherent viscosity of HA polymer, making the HAÀliposomes sticky and separation of unconjugated HMWHA from HAÀliposome preparations is not efficient. Free HMWHA may compete with the HAÀliposomes for receptor binding sites and hamper the uptake of HAÀliposomes. Therefore, 1600 kDa HMWHA may not be an ideal ligand for coating liposomes despite its high receptor binding affinity. The optimal size of HA for construction of tumor-targeted HAÀliposomes will have to balance the receptor affinity, circulation half-life, and tumor/liver accumulation ratios. In principle, linear HA polymer can behave just like PEG. This means, depending on the size of HA and grafting density, HA chains grafted on the lipid bilayers can show brush, mushroom, or pancake conformation. Each conformation has different thickness of hydration layer and different steric hindrance. 57 All of these could potentially affect circulation halflife. Shorter polymer chain length may have longer circulation, as PEG 5000 liposomes show similar or even reduced circulation times compared to PEG 2000 liposomes at similar lipid-to-polymer mole ratios. 58 Nevertheless, our results indicate that both the HA MW and grafting density should be tuned to be effective by either high affinity ligand or high density of multiple ligands with moderate affinity. Future studies of the biodistribution and intratumoral accumulation of different MWs of HAÀliposomes in tumorbearing animal models will allow selecting HAÀliposome with optimized pharmacokinetics and tumor targeting properties.
Cells use endocytosis as a tool to internalize a variety of cargos. The receptor-mediated endocytosis is a complex and highly regulated process, which involves the binding, internalization, and transfer of ligands through a series of distinct intracellular compartments. A recent report 59 showed that the endocytic patternings of anti-EGFR antibody C225 and gold-conjugated C225 nanoparticles were different. Thus, the nanoconjugation may potentially alter and modulate the endocytic pathways. 59 The mechanism and pattern of free HA polymer-induced endocytosis is still not fully understood. 34 Indeed, some have even argued that the mammalian endocytic HA receptor is HARE instead of CD44. 14, 60, 61 Furthermore, it is unknown whether nanoconjugation could lead to the alteration of the mechanism of endocytosis of HAÀliposomes.
In the current study, we observed that the CD44-mediated internalization of HAÀliposomes occurs via the lipid raftmediated endocytosis pathway and is independent of clathrincoated vesicles or the caveolae or macropinocytosis pathways ( Figure 6 ). Lipid rafts are dynamic assemblies in cell membranes enriched in cholesterol and sphingolipids such as sphingomyelin and gangliosides. 62 These specialized membrane microdomains exhibit more ordered and tightly packed bilayers and float freely in the plasma membrane. Lipid rafts serve as a platform for assembly of signaling molecules, eliciting controlled signal transduction, and influencing membrane protein and cellular receptor trafficking. 39, 62, 63 Previous studies showed that CD44 localizes in detergent-resistant cholesterol-rich lipid rafts 64 and associates directly or indirectly with signaling proteins and transporters. 65À67 Both HMWHA and LMWHA can rapidly recruit CD44s to the lipid raft fraction. 68 Moreover, recent reports show that disintegration of membrane lipid rafts by MβCD enhances CD44 shedding. 67 Our results ( Figure 6 ) indicate that, similar to free HA polymer, HAÀliposomes are taken up via lipid raft-mediated endocytosis, which is energy and cholesterol dependent. Depletion of cholesterol by MβCD could potentially lead to shedding of CD44 receptors in the lipid raft and result in the reduced HAÀliposome uptake, as observed in our studies ( Figure 6 ).
We have demonstrated that a fraction of the endocytosed HAÀliposomes resides in low pH intracellular compartments such as endolysosomal vesicles (Figure 7) . This is consistent with published data showing that free HA resides in prelysosomal endosomes. 34 Intracellular trafficking of HAÀliposomes is a highly dynamic process as receptor CD44 rapidly recycles from the intracellular compartment to the plasma membrane. The intracellular fate of HAÀliposomes will impact the specific delivery and release of cargos and elicit downstream pharmacodynamic effect.
In summary, the maximum HAÀliposomeÀCD44 receptor binding effect can be achieved by increasing either HA chain length or grafting density. HAÀliposomes mainly reside in low pH intracellular compartments. Fine tuning the HA molecular weight and grafting density will optimize the HAÀliposomes for improved intratumoral delivery. This information is crucial for the design of optimal formulations for the in vivo delivery of anticancer therapeutics using hyaluronan-conjugated delivery systems. 
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